CA2541337C - Systeme d'assistance circulatoire - Google Patents
Systeme d'assistance circulatoire Download PDFInfo
- Publication number
- CA2541337C CA2541337C CA002541337A CA2541337A CA2541337C CA 2541337 C CA2541337 C CA 2541337C CA 002541337 A CA002541337 A CA 002541337A CA 2541337 A CA2541337 A CA 2541337A CA 2541337 C CA2541337 C CA 2541337C
- Authority
- CA
- Canada
- Prior art keywords
- pump housing
- blood
- heart
- inlet
- pump
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008280 blood Substances 0.000 claims abstract description 67
- 210000004369 blood Anatomy 0.000 claims abstract description 67
- 238000005086 pumping Methods 0.000 claims abstract description 19
- 230000009467 reduction Effects 0.000 claims description 6
- 210000004204 blood vessel Anatomy 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 20
- 210000000709 aorta Anatomy 0.000 abstract description 18
- 210000004072 lung Anatomy 0.000 abstract description 9
- 210000005246 left atrium Anatomy 0.000 abstract description 8
- 238000006213 oxygenation reaction Methods 0.000 abstract description 7
- 230000036961 partial effect Effects 0.000 abstract description 5
- 238000001356 surgical procedure Methods 0.000 abstract description 5
- 210000005241 right ventricle Anatomy 0.000 abstract description 4
- 230000009885 systemic effect Effects 0.000 abstract description 4
- 210000005245 right atrium Anatomy 0.000 abstract description 3
- 239000013589 supplement Substances 0.000 abstract description 3
- 210000001367 artery Anatomy 0.000 abstract description 2
- 230000004088 pulmonary circulation Effects 0.000 abstract description 2
- 210000003462 vein Anatomy 0.000 abstract description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 15
- 210000005240 left ventricle Anatomy 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 230000007246 mechanism Effects 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 12
- 238000001514 detection method Methods 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 210000004115 mitral valve Anatomy 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 241001631457 Cannula Species 0.000 description 4
- 230000000994 depressogenic effect Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 210000003492 pulmonary vein Anatomy 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 206010019280 Heart failures Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000002837 heart atrium Anatomy 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 210000002376 aorta thoracic Anatomy 0.000 description 2
- 210000001765 aortic valve Anatomy 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 238000000375 direct analysis in real time Methods 0.000 description 2
- 238000012063 dual-affinity re-targeting Methods 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000013022 venting Methods 0.000 description 2
- 241001149900 Fusconaia subrotunda Species 0.000 description 1
- 230000005355 Hall effect Effects 0.000 description 1
- 241001055071 Peperomia marmorata Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 229940100084 cardioplegia solution Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 210000003270 subclavian artery Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2665796P | 1996-10-04 | 1996-10-04 | |
| US2807096P | 1996-10-04 | 1996-10-04 | |
| US2665696P | 1996-10-04 | 1996-10-04 | |
| US60/026,656 | 1996-10-04 | ||
| US60/028,070 | 1996-10-04 | ||
| US60/026,657 | 1996-10-04 | ||
| CA002268066A CA2268066C (fr) | 1996-10-04 | 1997-10-03 | Systeme d'assistance circulatoire |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002268066A Division CA2268066C (fr) | 1996-10-04 | 1997-10-03 | Systeme d'assistance circulatoire |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2541337A1 CA2541337A1 (fr) | 1998-04-09 |
| CA2541337C true CA2541337C (fr) | 2009-07-14 |
Family
ID=36636782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002541337A Expired - Fee Related CA2541337C (fr) | 1996-10-04 | 1997-10-03 | Systeme d'assistance circulatoire |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2541337C (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109303937B (zh) * | 2018-11-02 | 2023-04-14 | 重庆医科大学附属第三医院(捷尔医院) | 左心引流管的自动减压调节装置 |
-
1997
- 1997-10-03 CA CA002541337A patent/CA2541337C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2541337A1 (fr) | 1998-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2268066C (fr) | Systeme d'assistance circulatoire | |
| WO1998014225A9 (fr) | Systeme d'assistance circulatoire | |
| EP1481698B1 (fr) | Appareil d'assistance circulatoire | |
| AU2001292637B2 (en) | Method and system for closed chest blood flow support | |
| JP4179634B2 (ja) | 心内血液ポンプ | |
| US5888241A (en) | Cannula pumps for temporary cardiac support and methods of their application and use | |
| US6176822B1 (en) | Intracardiac blood pump | |
| EP1019117B1 (fr) | Unité de contrôle pour système de pompage implantable | |
| USRE43299E1 (en) | Paracardiac blood pump | |
| AU2001292637A1 (en) | Method and system for closed chest blood flow support | |
| CN1222862A (zh) | 心内泵装置 | |
| JP2000000299A (ja) | 制御機能を備えた体外循環装置 | |
| CA2541337C (fr) | Systeme d'assistance circulatoire | |
| EP1263495B1 (fr) | Systeme de cannulation | |
| WO2001083021A1 (fr) | Systeme de canulation et procedes associes | |
| CN116328173A (zh) | 一种辅助心脏泵血的监测导管、监测系统及方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed | ||
| MKLA | Lapsed |
Effective date: 20111003 |